Bollard Group LLC Pfizer Inc Transaction History

Bollard Group LLC

  • $3.81 Billion
  • Q1 2025

A detailed history of Bollard Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bollard Group LLC holds 29,582 shares of PFE stock, worth $710,855. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,582
Previous 31,678 6.62%
Holding current value
$710,855
Previous $840,000 10.71%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$25.01 - $27.13 $52,420 - $56,864
-2,096 Reduced 6.62%
29,582 $750,000
Q4 2024

Feb 14, 2025
SELL
$24.8 - $30.19 $41,440 - $50,447
-1,671 Reduced 5.01%
31,678 $840,000
Q3 2024

Nov 13, 2024
SELL
$27.7 - $31.39 $6,703 - $7,596
-242 Reduced 0.72%
33,349 $965,000
Q2 2024

Aug 14, 2024
SELL
$25.26 - $29.6 $1.07 Million - $1.25 Million
-42,349 Reduced 55.77%
33,591 $940,000
Q1 2024

May 13, 2024
BUY
$25.89 - $29.73 $22,032 - $25,300
851 Added 1.13%
75,940 $2.11 Million
Q4 2023

Feb 13, 2024
SELL
$26.13 - $33.94 $95,113 - $123,541
-3,640 Reduced 4.62%
75,089 $2.16 Million
Q3 2023

Nov 14, 2023
BUY
$32.09 - $37.51 $7,573 - $8,852
236 Added 0.3%
78,729 $2.61 Million
Q2 2023

Aug 14, 2023
BUY
$36.12 - $41.79 $16,904 - $19,557
468 Added 0.6%
78,493 $2.88 Million
Q1 2023

May 12, 2023
BUY
$39.39 - $51.28 $7,956 - $10,358
202 Added 0.26%
78,025 $3.18 Million
Q4 2022

Feb 10, 2023
SELL
$41.75 - $54.5 $109,343 - $142,735
-2,619 Reduced 3.26%
77,823 $3.99 Million
Q3 2022

Nov 09, 2022
SELL
$43.76 - $53.42 $27,831 - $33,975
-636 Reduced 0.78%
80,442 $3.52 Million
Q2 2022

Aug 12, 2022
BUY
$46.53 - $55.17 $7,956 - $9,434
171 Added 0.21%
81,078 $4.25 Million
Q1 2022

May 12, 2022
BUY
$45.75 - $56.69 $8,829 - $10,941
193 Added 0.24%
80,907 $4.19 Million
Q4 2021

Feb 11, 2022
BUY
$41.32 - $61.25 $6,776 - $10,045
164 Added 0.2%
80,714 $4.77 Million
Q3 2021

Nov 12, 2021
BUY
$39.25 - $50.42 $7,850 - $10,084
200 Added 0.25%
80,550 $3.46 Million
Q2 2021

Aug 12, 2021
BUY
$35.91 - $40.68 $8,510 - $9,641
237 Added 0.3%
80,350 $3.15 Million
Q1 2021

May 11, 2021
BUY
$33.49 - $37.77 $535 - $604
16 Added 0.02%
80,113 $2.9 Million
Q4 2020

Feb 04, 2021
SELL
$33.47 - $42.56 $32,934 - $41,879
-984 Reduced 1.21%
80,097 $2.95 Million
Q3 2020

Nov 12, 2020
SELL
$31.75 - $37.25 $24,225 - $28,421
-763 Reduced 0.93%
81,081 $2.98 Million
Q2 2020

Aug 13, 2020
BUY
$30.12 - $36.54 $166,684 - $202,212
5,534 Added 7.25%
81,844 $2.68 Million
Q1 2020

May 14, 2020
SELL
$27.03 - $38.62 $219,051 - $312,976
-8,104 Reduced 9.6%
76,310 $2.49 Million
Q4 2019

Feb 10, 2020
BUY
$32.92 - $37.36 $18,764 - $21,295
570 Added 0.68%
84,414 $3.31 Million
Q3 2019

Nov 13, 2019
BUY
$32.49 - $42.13 $19,851 - $25,741
611 Added 0.73%
83,844 $3.01 Million
Q2 2019

Aug 13, 2019
BUY
$36.98 - $41.52 $19,377 - $21,756
524 Added 0.63%
83,233 $3.61 Million
Q1 2019

May 10, 2019
BUY
$37.5 - $41.2 $19,387 - $21,300
517 Added 0.63%
82,709 $3.51 Million
Q4 2018

Feb 05, 2019
BUY
$38.47 - $43.86 $48,318 - $55,088
1,256 Added 1.55%
82,192 $3.59 Million
Q3 2018

Nov 08, 2018
BUY
$34.47 - $41.81 $18,648 - $22,619
541 Added 0.67%
80,936 $3.57 Million
Q2 2018

Aug 09, 2018
BUY
$32.98 - $35.16 $20,249 - $21,588
614 Added 0.77%
80,395 $2.92 Million
Q1 2018

May 14, 2018
BUY
$31.91 - $37.02 $19,337 - $22,434
606 Added 0.77%
79,781 $2.83 Million
Q4 2017

Jan 29, 2018
BUY
$33.26 - $35.29 $18,858 - $20,009
567 Added 0.72%
79,175 $2.87 Million
Q3 2017

Oct 27, 2017
BUY
$31.0 - $34.15 $2.44 Million - $2.68 Million
78,608
78,608 $2.81 Million

Others Institutions Holding PFE

# of Institutions
3,370
Shares Held
3.61B
Call Options Held
102M
Put Options Held
130M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $135B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email